Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Hoffmann-La Roche
Jazz Pharmaceuticals
Baylor College of Medicine
VM Oncology, LLC
Cancer Research UK
Bayer
LigaChem Biosciences, Inc.
Merck Sharp & Dohme LLC
Washington University School of Medicine
Jonsson Comprehensive Cancer Center
Convalife (Shanghai) Co., Ltd.
Universitair Ziekenhuis Brussel
Hoffmann-La Roche
Klus Pharma Inc.
Eastern Cooperative Oncology Group
Xencor, Inc.
MacroGenics
AIDS Malignancy Consortium
Stanford University
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
University of Arizona
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Duke University
National Cancer Institute (NCI)
INSYS Therapeutics Inc
National Cancer Institute (NCI)
Dartmouth-Hitchcock Medical Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Duke University
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
European Organisation for Research and Treatment of Cancer - EORTC
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
European Organisation for Research and Treatment of Cancer - EORTC
NYU Langone Health
Case Comprehensive Cancer Center